Hallett David 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed May 19, 2026
Research Summary
AI-generated summary of this filing
RECURSION (RXRX) CSO David Hallett Withholds 26,657 Shares for Taxes
What Happened
- David Hallett, Chief Scientific Officer of Recursion Pharmaceuticals (RXRX), had 26,657 shares disposed/withheld on May 15, 2026 to satisfy tax withholding related to the net settlement of restricted stock units. The withheld shares were recorded at $3.04 per share for a total value of $81,037.
Key Details
- Transaction date: 2026-05-15; Filing date: 2026-05-19 (filed timely).
- Transaction type/code: F — shares withheld to cover tax withholding (disposition on Form 4).
- Amount: 26,657 shares withheld at $3.04 per share; total value ≈ $81,037.
- Footnote: F1 — issuer withheld shares to satisfy its tax withholding/remittance obligations in connection with net settlement of RSUs.
- Shares owned after transaction: Not specified in the provided filing details.
Context
- This was an administrative tax-withholding (net settlement of RSUs), not an open-market sale. Withheld shares are retained by the issuer to cover taxes and do not necessarily reflect the insider’s view of the company’s stock.
Insider Transaction Report
Form 4
Hallett David
Chief Scientific Officer
Transactions
- Tax Payment
Class A Common Stock
[F1]2026-05-15$3.04/sh−26,657$81,037→ 1,070,494 total
Footnotes (1)
- [F1]Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
Signature
/s/Jonathan Golightly, attorney-in-fact|2026-05-18